Rigvir SE contains Vitamin B2, whey protein isolate and traces of a lyophilised non-genetically modified and non-pathogenic ECHO-7 virus Rigvir.

Rigvir SE ingredients are included in a capsule with special coating (hydroxypropyl methylcellulose) that allows it to cross the stomach and reach the intestine which is the most suitable environment for the ECHO-7 virus to provide its maximum benefit. The amount of ECHO-7 virus is multiple times smaller than the one used in the production of the Rigvir medicine.

Rigvir SE contains milk; does not contain gluten, wheat, yeast or soy.

It is important to observe temperature regimen in the storage and during transportation of Rigvir SE.

Rigvir SE active ingredient ECHO-7 virus is internationally patented.

Note. ECHO-7 virus Rigvir in the form of injectable medicine has been registered in 2004 and is still successfully used these days in the treatment of various cancer types and prevention of metastasis, as well as by people with increased cancer risks. 

More information on:

• Rigvir virus producer’s web page – www.rigvir.com
• National Library of Medicine – www.pubmed.ncbi.nlm.nih.gov/?term=RIGVIR
•  “The advent of oncolytic virotherapy in oncology: The Rigvir® story” – www.sciencedirect.com/science/article/pii/S0014299918305053
•  Patient testimonials – www.youtube.com/user/CancerVirotherapy